|
Market Closed -
Oslo Bors
10:45:00 2026-09-01 am EDT
|
5-day change | 1st Jan Change | ||
| 0.7500 NOK | -2.60% |
|
0.00% | -45.65% |
| Jun. 30 | Exact Therapeutics to Delist from Euronext Growth Oslo in October | MT |
| Jun. 26 | EXACT Therapeutics AS Gets Positive Safety Review For 60 ?l/Kg Dose In Phase 2 ENACT Trial | RE |
| Market Cap | 48.71M 5.21M 4.49M 4.21M 3.85M 7.23M 496M 7.28M 49.93M 19.43M 251M 19.57M 19.14M 833M | P/E 2024 |
-2.49x | P/E 2025 | -1x |
|---|---|---|---|---|---|
| Enterprise Value | 24.8M 2.65M 2.28M 2.15M 1.96M 3.68M 252M 3.71M 25.42M 9.89M 128M 9.96M 9.75M 424M | EV / Sales 2024 |
-
| EV / Sales 2025 | 1,074,437,000x |
| Free-Float |
30.97% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -2.60% | ||
| Current month | -2.60% | ||
| 1 month | -6.25% | ||
| 3 months | +13.64% | ||
| 6 months | -55.88% | ||
| Current year | -45.65% |
| 1 week | 0.7 |  | 0.8 |
| 1 month | 0.68 | | 0.8 |
| Current year | 0.58 | | 2.7 |
| 1 year | 0.58 | | 2.98 |
| 3 years | 0.58 | | 20 |
| 5 years | 0.58 | | 23 |
| 10 years | 0.58 | | 53.59 |
| Manager | Title | Age | Since |
|---|---|---|---|
Per Walday
CEO | Chief Executive Officer | 66 | 2022-06-05 |
Svein Kvåle
COO | Chief Operating Officer | - | 2011-12-31 |
John Edminson
DFI | Director of Finance/CFO | - | 2022-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 55 | 2018-06-21 | |
Anders Wold
CHM | Chairman | - | 2022-06-07 |
| Director/Board Member | 59 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 1/4/23 | Buy | Chairman | 2,500 | 0.0083% | ||
| 1/4/23 | Buy | Founder | 2,500 | 0.0083% | ||
| 1/4/23 | Buy | Chief Financial Officer | 2,500 | 0.0083% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.60% | 0.00% | -68.75% | -93.18% | 5.21M | |
| +0.21% | -2.69% | +1.19% | +17.32% | 49.81B | |
| +1.32% | -1.67% | +425.78% | +492.98% | 44.06B | |
| -0.82% | -0.00% | +41.18% | +15.64% | 42.99B | |
| -0.36% | -4.80% | +7.91% | +71.50% | 40.88B | |
| -0.48% | -3.09% | +17.78% | +49.80% | 33.11B | |
| -1.41% | -4.46% | +23.94% | +114.51% | 16.58B | |
| -1.30% | +3.02% | - | - | 17.27B | |
| -1.35% | -3.40% | +10.13% | +26.34% | 14.63B | |
| -1.35% | -4.32% | +76.61% | +35.86% | 13.76B | |
| Average | -0.77% | -1.21% | +59.53% | +81.20% | 27.31B | |
| Weighted average by Cap. | -0.21% | -1.79% | +90.30% | +119.63% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 0.06 0.01 0.01 0.01 0 0.01 0.6 0.01 0.06 0.02 0.3 0.02 0.02 1.01 |
| Net income | -52.33M -5.6M -4.82M -4.53M -4.13M -7.76M -533M -7.82M -53.64M -20.87M -270M -21.02M -20.57M -895M | -86.97M -9.31M -8.01M -7.52M -6.87M -12.9M -885M -12.99M -89.14M -34.68M -449M -34.94M -34.18M -1.49B |
| Net Debt | -98.89M -10.58M -9.11M -8.55M -7.81M -14.67M -1.01B -14.77M -101M -39.44M -511M -39.73M -38.87M -1.69B | -23.91M -2.56M -2.2M -2.07M -1.89M -3.55M -243M -3.57M -24.51M -9.54M -123M -9.61M -9.4M -409M |
Employees
11
Calendar
Sep. 02
Earnings release - Q2 2026
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-01 | NOK 0.7500 | -2.60% | 25,156 |
| 26-08-31 | NOK 0.7700 | +10.79% | 21,233 |
| 26-08-28 | NOK 0.6950 | -6.08% | 30,500 |
| 26-08-27 | NOK 0.7400 | -6.92% | 34,318 |
| 26-08-26 | NOK 0.7950 | +6.00% | 22,982 |
- Stock Market
- Stocks
- EXTX Stock
Select your edition
All financial news and data tailored to specific country editions
